SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-024854
Filing Date
2021-07-19
Accepted
2021-07-19 21:29:25
Documents
2
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1529
2 EXHIBIT 24 brhc10027050_ex24.htm EX-24 9744
  Complete submission text file 0001140361-21-024854.txt   12993
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220
Business Address
Sial Jay (Reporting) CIK: 0001873057 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 211099272